Targeting Multiple EGFR-expressing Tumors with a Highly Potent Tumor-selective Antibody-Drug Conjugate.
Anderson MG, Falls HD, Mitten MJ, Oleksijew A, Vaidya KS, Boghaert ER, Gao W, Palma JP, Cao D, Chia PL, John T, Gan HK, Scott AM, Reilly EB.
Anderson MG, et al. Among authors: scott am.
Mol Cancer Ther. 2020 Oct;19(10):2117-2125. doi: 10.1158/1535-7163.MCT-20-0149. Epub 2020 Aug 26.
Mol Cancer Ther. 2020.
PMID: 32847977